Asimov Engineering Blog

The Biorisk Question

In June 1972, a graduate student at Stanford University named Janet Mertz made a discovery that expanded the possibilities of molecular biology, but…

Oct 13

February 2024

Making Lenti

Explaining the research behind LV Edge, our suite of cells and tools to streamline lentivirus manufacturing. Part II in our series on Engineered Cell…

Feb 22, 2024

12

January 2024

Engineered Cell Therapies

Lentiviruses are the backbone of many engineered cell therapies, but remain expensive to make and difficult to scale. Our LV Edge system can help. Part…

Jan 30, 2024

9

6

Central Dogma in 7 Experiments

A brief history of molecular biology’s seminal achievement.

Jan 16, 2024

10

2

November 2023

Metabolic Simulator

Computational models for CHO cells boost antibody titers by 25 percent.

Nov 1, 2023

11

2

October 2023

Medicine-Making Tools

Notes on CHO cells and antibodies.

Oct 18, 2023

17

1

September 2023

Announcing Asimov Press

Good ideas on the future of biology.

Sep 5, 2023

14

1

August 2023

Genetic Design in 7 Experiments

A brief history of using computers to design biology.

Aug 16, 2023

14

3

Asimov Labs

A moonshot for genetic design.

Aug 2, 2023

7

2

July 2023

GitHub is to Code as ___ is to DNA

Software to grow biological communities.

Jul 6, 2023

15

1

June 2023

AI-Designed Promoters

Part II on Making Better Gene Therapies

Jun 20, 2023

14

1

Making Better Gene Therapies

Part 1: AAV Foundations

Jun 6, 2023

12

2